Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$190.62
2.751.46%
al cierre: Nov 21, 4:00 PM EST
$190.61
-0.01-0.01%
After hour: Nov 21, 7:36 PM EST
Comments
Loading...
Calificaciones de analistas, precios objetivo, pronóstico
Marathon Petroleum Corp tiene un precio objetivo de consenso de $196 basado en las calificaciones de 20 analistas. El máximo es $231, emitido por Piper Sandler el noviembre 14, 2025. El mínimo es $152, emitido por RBC Capital el agosto 2, 2023. Las 3 calificaciones de analistas más recientes fueron publicadas por Barclays, Piper Sandler y Wells Fargo el noviembre 17, 2025, noviembre 14, 2025 y noviembre 5, 2025, respectivamente. Con un precio objetivo promedio de $215.33 entre Barclays, Piper Sandler y Wells Fargo, hay una 12.97% upside implícita para Marathon Petroleum Corp según estas calificaciones más recientes de analistas.
Firmas de analistas que realizan recomendaciones1
Barclays
Piper Sandler
Wells Fargo
Raymond James
Scotiabank
1calculado a partir de las calificaciones de los analistas
Calificaciones de analistas para Marathon Petroleum
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
11/17/2025 | 5.98% | Barclays | $194 → $202 | Maintains | Overweight | |||
11/14/2025 | 21.19% | Piper Sandler | $220 → $231 | Maintains | Neutral | |||
11/05/2025 | 11.75% | Wells Fargo | $214 → $213 | Maintains | Overweight | |||
10/17/2025 | 6.5% | Raymond James | $199 → $203 | Reiterates | Outperform → Outperform | |||
10/17/2025 | 12.27% | Wells Fargo | → $214 | Initiates | → Overweight | |||
10/13/2025 | 1.78% | Barclays | $176 → $194 | Maintains | Overweight | |||
10/09/2025 | -0.84% | Scotiabank | $180 → $189 | Maintains | Sector Outperform | |||
10/03/2025 | 4.93% | Morgan Stanley | $182 → $200 | Maintains | Overweight | |||
09/26/2025 | 15.42% | UBS | $203 → $220 | Maintains | Buy | |||
09/19/2025 | 10.17% | Evercore ISI Group | $170 → $210 | Maintains | In-Line | |||
09/15/2025 | -1.37% | Mizuho | $184 → $188 | Maintains | Neutral | |||
09/11/2025 | 16.47% | Piper Sandler | $184 → $222 | Maintains | Neutral | |||
09/09/2025 | 4.4% | Raymond James | $195 → $199 | Maintains | Outperform | |||
09/03/2025 | 0.73% | B of A Securities | $184 → $192 | Maintains | Neutral | |||
07/22/2025 | -4.52% | Piper Sandler | $175 → $182 | Maintains | Neutral | |||
07/16/2025 | -4.52% | Citigroup | $144 → $182 | Maintains | Neutral | |||
07/16/2025 | -4.52% | Morgan Stanley | $160 → $182 | Maintains | Overweight | |||
07/15/2025 | 4.93% | Raymond James | $180 → $200 | Downgrade | Strong Buy → Outperform | |||
07/14/2025 | — | Wolfe Research | — | Downgrade | Outperform → Peer Perform | |||
07/11/2025 | -5.57% | Scotiabank | $147 → $180 | Maintains | Sector Outperform | |||
07/11/2025 | -0.84% | Barclays | $159 → $189 | Maintains | Overweight | |||
07/10/2025 | 6.5% | UBS | $175 → $203 | Maintains | Buy | |||
07/10/2025 | -8.19% | Piper Sandler | $157 → $175 | Maintains | Neutral | |||
07/10/2025 | 7.55% | Wells Fargo | $182 → $205 | Maintains | Overweight | |||
06/30/2025 | -1.37% | Raymond James | $183 → $188 | Maintains | Strong Buy | |||
06/18/2025 | -10.81% | Evercore ISI Group | → $170 | Initiates | → In-Line | |||
06/11/2025 | -4.52% | Wells Fargo | $180 → $182 | Maintains | Overweight | |||
05/13/2025 | -5.57% | Wells Fargo | $175 → $180 | Maintains | Overweight | |||
05/13/2025 | -3.47% | Mizuho | $168 → $184 | Maintains | Neutral | |||
05/12/2025 | -16.58% | Barclays | $141 → $159 | Maintains | Overweight | |||
04/24/2025 | -16.06% | Morgan Stanley | $175 → $160 | Maintains | Overweight | |||
04/14/2025 | -26.03% | Barclays | $161 → $141 | Maintains | Overweight | |||
04/11/2025 | -22.88% | Scotiabank | $169 → $147 | Maintains | Sector Outperform | |||
04/11/2025 | -8.19% | Wells Fargo | $185 → $175 | Maintains | Overweight | |||
04/10/2025 | -11.86% | Mizuho | $174 → $168 | Maintains | Neutral | |||
04/09/2025 | -3.99% | Raymond James | $193 → $183 | Maintains | Strong Buy | |||
03/21/2025 | -2.94% | Wells Fargo | $183 → $185 | Maintains | Overweight | |||
03/14/2025 | -15.53% | Barclays | $159 → $161 | Maintains | Overweight | |||
03/07/2025 | -18.16% | Piper Sandler | $160 → $156 | Maintains | Neutral | |||
02/05/2025 | -3.99% | Wells Fargo | $182 → $183 | Maintains | Overweight | |||
01/17/2025 | 0.73% | Raymond James | $190 → $192 | Maintains | Strong Buy | |||
01/10/2025 | -4.52% | Wells Fargo | $186 → $182 | Maintains | Overweight | |||
12/16/2024 | -8.71% | Mizuho | $175 → $174 | Maintains | Neutral | |||
12/09/2024 | -2.42% | Wells Fargo | $183 → $186 | Maintains | Overweight | |||
11/11/2024 | -16.58% | Barclays | $168 → $159 | Maintains | Overweight | |||
11/06/2024 | -10.81% | TD Cowen | $174 → $170 | Maintains | Buy | |||
10/10/2024 | -12.39% | Citigroup | $172 → $167 | Maintains | Neutral | |||
10/10/2024 | -10.81% | Scotiabank | $191 → $170 | Maintains | Sector Outperform | |||
10/10/2024 | -11.86% | Barclays | $180 → $168 | Maintains | Overweight | |||
10/09/2024 | -10.29% | JP Morgan | $172 → $171 | Maintains | Neutral | |||
10/09/2024 | -3.99% | Wells Fargo | $196 → $183 | Maintains | Overweight | |||
10/04/2024 | -0.32% | BMO Capital | $200 → $190 | Maintains | Outperform | |||
10/02/2024 | -9.76% | JP Morgan | $186 → $172 | Maintains | Neutral | |||
09/20/2024 | -23.93% | Piper Sandler | $168 → $145 | Maintains | Neutral | |||
09/16/2024 | -4.52% | Morgan Stanley | $196 → $182 | Maintains | Overweight | |||
09/16/2024 | 1.25% | Mizuho | $198 → $193 | Maintains | Neutral | |||
08/07/2024 | -0.32% | TD Cowen | $187 → $190 | Maintains | Buy | |||
07/18/2024 | — | Wolfe Research | — | Reinstates | → Outperform | |||
07/15/2024 | 21.19% | Jefferies | $222 → $231 | Maintains | Buy | |||
07/12/2024 | 0.2% | Scotiabank | $207 → $191 | Maintains | Sector Outperform | |||
07/12/2024 | 2.83% | Wells Fargo | $223 → $196 | Maintains | Overweight | |||
07/02/2024 | -2.42% | JP Morgan | $191 → $186 | Maintains | Neutral | |||
07/01/2024 | -2.94% | Barclays | $195 → $185 | Maintains | Overweight | |||
06/20/2024 | 5.45% | Mizuho | $203 → $201 | Maintains | Neutral | |||
06/14/2024 | -11.86% | Piper Sandler | $190 → $168 | Maintains | Neutral | |||
06/06/2024 | 16.99% | Wells Fargo | $227 → $223 | Maintains | Overweight | |||
05/30/2024 | 20.67% | Raymond James | $235 → $230 | Maintains | Strong Buy | |||
05/14/2024 | -0.32% | Piper Sandler | $204 → $190 | Maintains | Neutral | |||
05/13/2024 | 6.5% | Mizuho | $200 → $203 | Maintains | Neutral | |||
05/06/2024 | 2.3% | Barclays | $221 → $195 | Maintains | Overweight | |||
05/02/2024 | 4.93% | Mizuho | $202 → $200 | Maintains | Neutral | |||
04/12/2024 | 5.98% | Mizuho | $201 → $202 | Maintains | Neutral | |||
04/11/2024 | 8.6% | Scotiabank | $175 → $207 | Maintains | Sector Outperform | |||
04/05/2024 | 15.94% | Barclays | $168 → $221 | Maintains | Overweight | |||
04/05/2024 | 7.02% | Piper Sandler | $159 → $204 | Maintains | Neutral | |||
04/04/2024 | 19.09% | Wells Fargo | $214 → $227 | Maintains | Overweight | |||
04/01/2024 | -2.42% | JP Morgan | $172 → $186 | Maintains | Neutral | |||
03/22/2024 | 10.7% | Goldman Sachs | $175 → $211 | Maintains | Buy | |||
03/22/2024 | 5.45% | Mizuho | $159 → $201 | Maintains | Neutral | |||
03/20/2024 | 12.27% | Wells Fargo | $183 → $214 | Maintains | Overweight | |||
03/15/2024 | 20.67% | B of A Securities | $185 → $230 | Maintains | Neutral | |||
02/05/2024 | -11.86% | Barclays | $163 → $168 | Maintains | Overweight | |||
01/31/2024 | -2.94% | Raymond James | $175 → $185 | Maintains | Strong Buy | |||
12/14/2023 | -11.34% | Wells Fargo | → $169 | Upgrade | Equal-Weight → Overweight | |||
11/01/2023 | -8.19% | Raymond James | $171 → $175 | Maintains | Strong Buy | |||
10/17/2023 | -16.06% | Morgan Stanley | $150 → $160 | Maintains | Overweight | |||
10/06/2023 | -12.91% | Mizuho | $178 → $166 | Maintains | Neutral | |||
10/06/2023 | -10.29% | Raymond James | $177 → $171 | Maintains | Strong Buy | |||
10/05/2023 | -22.35% | Piper Sandler | $146 → $148 | Maintains | Neutral | |||
09/20/2023 | -7.14% | Raymond James | $165 → $177 | Maintains | Strong Buy | |||
09/18/2023 | -9.24% | B of A Securities | $162 → $173 | Maintains | Neutral | |||
09/18/2023 | -6.62% | Mizuho | $161 → $178 | Maintains | Neutral | |||
09/08/2023 | -17.63% | Wells Fargo | $142 → $157 | Maintains | Equal-Weight | |||
08/16/2023 | — | Mizuho | — | Downgrade | Buy → Neutral | |||
08/15/2023 | -15.01% | B of A Securities | $159 → $162 | Downgrade | Buy → Neutral | |||
08/07/2023 | -13.96% | Jefferies | $140 → $164 | Maintains | Buy | |||
08/07/2023 | -20.26% | Barclays | $132 → $152 | Maintains | Overweight | |||
08/02/2023 | -20.26% | RBC Capital | $148 → $152 | Maintains | Outperform | |||
08/02/2023 | -21.31% | Morgan Stanley | $150 → $150 | Reiterates | Overweight → Overweight | |||
08/02/2023 | -26.55% | Wells Fargo | $120 → $140 | Maintains | Equal-Weight |
PREGUNTAS FRECUENTES
¿Cuál es el precio objetivo de las acciones de Marathon Petroleum (MPC)?
El último precio objetivo de Marathon Petroleum (NYSE:MPC) fue comunicado por Barclays el noviembre 17, 2025. La firma de analistas fijó un precio objetivo para $202.00 que espera MPC a rise dentro de 12 meses (un posible 5.98% upside). 44 firmas de analistas han reportado calificaciones en el último año.
¿Cuál es la calificación más reciente de los analistas sobre Marathon Petroleum (MPC)?
La última calificación de analistas para Marathon Petroleum (NYSE:MPC) fue proporcionada por Barclays, y Marathon Petroleum mantuvo su overweight calificación.
¿Cuándo se produjo la última revisión al alza de Marathon Petroleum (MPC)?
La última revisión al alza de Marathon Petroleum Corp se produjo en diciembre 14, 2023, cuando Wells Fargo elevó su precio objetivo a $169. Wells Fargo anteriormente tenía an equal-weight para Marathon Petroleum Corp.
¿Cuándo fue la última revisión a la baja de Marathon Petroleum (MPC)?
La última revisión a la baja de Marathon Petroleum Corp se produjo en julio 15, 2025, cuando Raymond James cambió su precio objetivo de $180 a $200 para Marathon Petroleum Corp.
¿Cuándo se publicará o actualizará la próxima calificación de los analistas para Marathon Petroleum (MPC)?
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de Marathon Petroleum, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de Marathon Petroleum se registró el noviembre 17, 2025, por lo que la próxima calificación estará disponible en torno al noviembre 17, 2026.
¿Es correcta la calificación de los analistas sobre Marathon Petroleum (MPC)?
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de Marathon Petroleum (MPC) fue un mantuvo con un precio objetivo de $194.00 a $202.00. El precio actual al que cotiza Marathon Petroleum (MPC) es de $190.61, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.